pNTPTP alpha (Y789F)
(Plasmid
#17702)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 17702 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepTet-splice
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5178
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namePTPalpha Y789F
-
Alt namereceptor protein tyrosine phosphatase alpha
-
Alt nameRPTPalpha
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2379
-
MutationY789F
-
Entrez GenePTPRA (a.k.a. HEPTP, HLPR, HPTPA, HPTPalpha, LRP, PTPA, PTPRL2, R-PTP-alpha, RPTPA)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (unknown if destroyed)
- 3′ cloning site HindIII (unknown if destroyed)
- 5′ sequencing primer LNCX (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
See article for cloning details. The plasmid contains a CMV promoter under control of regulatory sequences from the tet operon such that, when cotransfected with the transactivator pTet-tTAk, it expresses protein only in the absence of doxycycline.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pNTPTP alpha (Y789F) was a gift from Xinmin Zheng (Addgene plasmid # 17702 ; http://n2t.net/addgene:17702 ; RRID:Addgene_17702) -
For your References section:
A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. Zheng XM, Resnick RJ, Shalloway D. EMBO J. 2000 Mar 1. 19(5):964-78. 10.1093/emboj/19.5.964 PubMed 10698938